NOBIVAC® Feline 1-HCPCh has been shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline rhinotracheitis, calici, and panleukopenia viruses, as well as feline Chlamydophila*.
Transfer contents of the diluent vial to the Nobivac®: Feline 1-HCPCh vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.
Two doses are required for primary immunization.
Nobivac Feline 1-HCPCH is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc.
Click here for our Vaccine Shipping Schedule.
Nobivac®: Feline 1-HCPCh vaccine is a modified live virus and chlamydia vaccine for the vaccination of healthy cats as an aid in the prevention of disease caused by feline rhinotracheitis, calici, and panleukopenia viruses and Chlamydia psittaci.
DOSAGE AND ADMINISTRATION:
Transfer contents of the diluent vial to the Nobivac®: Feline 1-HCPCh vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.
Two doses are required for primary immunization.
Initial vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly at 9 weeks of age or older.
Second vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination. Annual revaccination with one dose is recommended. Following the advice of the American Veterinary Medical Association on Vaccination Principles, an appropriate revaccination program for individual animals should be made based upon veterinarian-client-patient relationships.
Do not vaccinate pregnant cats.
Click here for our Vaccine Shipping Schedule.